NeuBase Therapeutics, Inc. Operating Lease Liability
NeuBase Therapeutics, Inc. had Operating Lease Liability of $5.89 million as of 2022-09-30, per its 10-K filed 2022-12-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-12-21
- 2022-09-30: Operating Lease, Liability $5.89M.
- 2021-12-31: Operating Lease, Liability $6.11M.
- 2021-09-30: Operating Lease, Liability $6.18M.
- 2021-06-30: Operating Lease, Liability $6.18M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $5.89M 10-K · filed 2022-12-21 |
| 2021-12-31 | $6.11M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $6.18M 10-K · filed 2021-12-23 |
| 2021-06-30 | $6.18M 10-Q · filed 2021-08-13 |